Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 02-Apr-24 4:15 PM View:  | Intra-Cellular Therapies, I... (ITCI) | 31-Mar-24 | Grant | 260 | $69.20 | $17,992.00 | < 1% 99.23K to 99.5K | |
| 22-Mar-24 4:12 PM View: | Intra-Cellular Therapies, I... (ITCI) | 20-Mar-24 | Option Exercise | 20,000 | $18.56 | $371,200.00 | 25% 79.23K to 99.23K | |
| 22-Feb-24 7:23 PM View: | Royalty Pharma Plc (RPRX) | 20-Feb-24 | Conversion | 300,000 | -- | -- | 249% 120.29K to 420.29K | |
| 04-Jan-24 5:16 PM View: | Royalty Pharma Plc (RPRX) | 04-Jan-24 | Sale | 35,702 | $27.55 | $983,504.00 | (23%) 155.99K to 120.29K | |
| 04-Jan-24 5:16 PM View: | Royalty Pharma Plc (RPRX) | 03-Jan-24 | Sale | 199,098 | $27.79 | $5,532,280.00 | (56%) 355.09K to 155.99K | |
| 04-Jan-24 5:16 PM View: | Royalty Pharma Plc (RPRX) | 02-Jan-24 | Sale | 235,200 | $28.52 | $6,707,080.00 | (40%) 590.29K to 355.09K | |
| 03-Jan-24 6:46 PM View: | Intra-Cellular Therapies, I... (ITCI) | 31-Dec-23 | Grant | 251 | $71.62 | $17,976.60 | < 1% 78.98K to 79.23K | |
| 03-Jan-24 7:08 PM View: | Cibus, Inc. (CBUS) | 29-Dec-23 | Conversion | 1,500,000 | -- | -- | 50% 3.0M to 4.5M | |
| 03-Jan-24 7:08 PM View: | Cibus, Inc. (CBUS) | 29-Dec-23 | Conversion | 1,500,000 | -- | -- | (25%) 6.01M to 4.51M | |
| 03-Jan-24 7:08 PM View: | Cibus, Inc. (CBUS) | 29-Dec-23 | Acquisition (other) | 1,505,970 | -- | -- | 33% 4.5M to 6.01M | |
| 14-Dec-23 5:10 PM View: | Cibus, Inc. (CBUS) | 12-Dec-23 | Purchase | 517,107 | $10.58 | $5,470,990.00 | 23% 2.21M to 2.73M | |
| 14-Nov-23 10:00 PM View: | Royalty Pharma Plc (RPRX) | 13-Nov-23 | Conversion | 475,590 | -- | -- | 415% 114.7K to 590.29K | |
| 02-Oct-23 10:00 PM View: | Intra-Cellular Therapies, I... (ITCI) | 30-Sep-23 | Grant | 345 | $52.09 | $17,971.10 | < 1% 78.64K to 78.98K | |
| 14-Dec-23 5:10 PM View: | Cibus, Inc. (CBUS) | 27-Sep-23 | Disposition (other) | 39,476 | -- | -- | (2%) 2.25M to 2.21M | |
| 05-Jul-23 4:30 PM View: | Intra-Cellular Therapies, I... (ITCI) | 30-Jun-23 | Grant | 279 | $63.32 | $17,666.30 | < 1% 78.36K to 78.64K | |
| 26-Jun-23 4:14 PM View: | Royalty Pharma Plc (RPRX) | 23-Jun-23 | Grant | 7,747 | -- | -- | 7% 106.95K to 114.7K | |
| 02-Jun-23 7:05 AM View: | Cibus, Inc. (CBUS) | 01-Jun-23 | Purchase | 1,000 | $31.50 | $31,500.00 | < 1% 10.57M to 10.57M | |
| 02-Jun-23 7:05 AM View: | Cibus, Inc. (CBUS) | 31-May-23 | Grant | 848,662 | -- | -- | 13% 6.53M to 7.38M | |
| 02-Jun-23 7:05 AM View: | Cibus, Inc. (CBUS) | 31-May-23 | Grant | 121,809 | -- | -- | 2% 7.38M to 7.5M | |
| 02-Jun-23 7:05 AM View: | Cibus, Inc. (CBUS) | 31-May-23 | Grant | 5,401 | -- | -- | < 1% 7.5M to 7.5M | |
| 02-Jun-23 7:05 AM View: | Cibus, Inc. (CBUS) | 31-May-23 | Grant | 9,600 | -- | -- | < 1% 7.5M to 7.51M | |
| 02-Jun-23 7:05 AM View: | Cibus, Inc. (CBUS) | 31-May-23 | Grant | 1,529,220 | -- | -- | 20% 7.51M to 9.04M | |
| 02-Jun-23 7:05 AM View: | Cibus, Inc. (CBUS) | 31-May-23 | Grant | 1,526,860 | -- | -- | 17% 9.04M to 10.57M | |
| 22-May-23 8:36 PM View: | Royalty Pharma Plc (RPRX) | 22-May-23 | Sale | 1,750,000 | $32.82 | $57,435,000.00 | (94%) 1.86M to 106.95K | |
| 12-May-23 6:43 PM View: | Royalty Pharma Plc (RPRX) | 09-May-23 | Conversion | 300,000 | -- | -- | 19% 1.56M to 1.86M | |
| 04-Apr-23 5:01 PM View: | Intra-Cellular Therapies, I... (ITCI) | 31-Mar-23 | Grant | 313 | $54.15 | $16,949.00 | < 1% 78.05K to 78.36K | |
| 30-Mar-23 5:53 PM View: | Royalty Pharma Plc (RPRX) | 30-Mar-23 | Sale | 130,024 | $36.26 | $4,714,340.00 | (8%) 1.69M to 1.56M | |
| 30-Mar-23 5:53 PM View: | Royalty Pharma Plc (RPRX) | 29-Mar-23 | Sale | 9,926 | $36.95 | $366,766.00 | (< 1%) 1.7M to 1.69M | |
| 17-Feb-23 4:59 PM View: | Royalty Pharma Plc (RPRX) | 17-Feb-23 | Conversion | 1,500,000 | -- | -- | 762% 196.9K to 1.7M | |
| 03-Jan-23 4:18 PM View: | Intra-Cellular Therapies, I... (ITCI) | 30-Dec-22 | Grant | 321 | $52.92 | $16,987.30 | < 1% 77.73K to 78.05K | |
| 13-Dec-22 6:20 PM View: | Royalty Pharma Plc (RPRX) | 09-Dec-22 | Sale | 19,990 | $42.07 | $840,939.00 | (8%) 256.9K to 236.91K | |
| 21-Nov-22 6:12 PM View: | Royalty Pharma Plc (RPRX) | 17-Nov-22 | Sale | 120,000 | $42.33 | $5,079,920.00 | (32%) 376.9K to 256.9K | |
| 04-Oct-22 4:11 PM View: | Intra-Cellular Therapies, I... (ITCI) | 30-Sep-22 | Grant | 365 | $46.53 | $16,983.40 | < 1% 77.36K to 77.73K | (12%) |
| 15-Sep-22 7:56 PM View: | Royalty Pharma Plc (RPRX) | 15-Sep-22 | Sale | 52,025 | $42.21 | $2,195,960.00 | (12%) 428.92K to 376.9K | |
| 15-Sep-22 7:56 PM View: | Royalty Pharma Plc (RPRX) | 14-Sep-22 | Sale | 47,975 | $42.41 | $2,034,430.00 | (10%) 476.9K to 428.92K | |
| 11-Aug-22 5:07 PM View: | Royalty Pharma Plc (RPRX) | 09-Aug-22 | Sale | 45,000 | $43.73 | $1,967,820.00 | (9%) 521.9K to 476.9K | |
| 05-Jul-22 4:06 PM View: | Intra-Cellular Therapies, I... (ITCI) | 30-Jun-22 | Grant | 289 | $57.08 | $16,496.10 | < 1% 77.07K to 77.36K | |
| 29-Jun-22 6:02 PM View: | Royalty Pharma Plc (RPRX) | 29-Jun-22 | Sale | 30,000 | $42.17 | $1,265,240.00 | (5%) 551.9K to 521.9K | |
| 23-May-22 4:55 PM View: | Royalty Pharma Plc (RPRX) | 20-May-22 | Sale | 123,696 | $39.28 | $4,858,660.00 | (18%) 675.6K to 551.9K | |
| 23-May-22 4:55 PM View: | Royalty Pharma Plc (RPRX) | 19-May-22 | Sale | 26,304 | $40.09 | $1,054,650.00 | (4%) 701.9K to 675.6K | |
| 04-Apr-22 4:08 PM View: | Intra-Cellular Therapies, I... (ITCI) | 31-Mar-22 | Grant | 257 | $61.19 | $15,725.80 | < 1% 76.81K to 77.07K | |
| 30-Mar-22 6:46 PM View: | Royalty Pharma Plc (RPRX) | 29-Mar-22 | Sale | 60,000 | $38.59 | $2,315,320.00 | (8%) 761.9K to 701.9K | |
| 21-Mar-22 6:20 PM View: | Royalty Pharma Plc (RPRX) | 21-Mar-22 | Sale | 39,867 | $39.05 | $1,556,850.00 | (5%) 801.77K to 761.9K | |
| 18-Mar-22 8:12 PM View: | Intra-Cellular Therapies, I... (ITCI) | 18-Mar-22 | Sale | 20,637 | $61.18 | $1,262,510.00 | (21%) 97.45K to 76.81K | |
| 21-Mar-22 6:20 PM View: | Royalty Pharma Plc (RPRX) | 18-Mar-22 | Sale | 129,222 | $39.55 | $5,110,670.00 | (14%) 930.99K to 801.77K | |
| 18-Mar-22 8:12 PM View: | Intra-Cellular Therapies, I... (ITCI) | 17-Mar-22 | Sale | 141,499 | $60.33 | $8,536,650.00 | (59%) 238.95K to 97.45K | |
| 21-Mar-22 6:20 PM View: | Royalty Pharma Plc (RPRX) | 17-Mar-22 | Acquisition (other) | 68,964 | -- | -- | 3% 2.7M to 2.77M | |
| 21-Mar-22 6:20 PM View: | Royalty Pharma Plc (RPRX) | 17-Mar-22 | Disposition (other) | 1,836,490 | -- | -- | (66%) 2.77M to 930.99K | |
| 18-Mar-22 8:12 PM View: | Intra-Cellular Therapies, I... (ITCI) | 16-Mar-22 | Private Sale | 64,534 | $59.27 | $3,824,830.00 | (21%) 303.49K to 238.95K | |
| 04-Jan-22 10:00 PM View: | Intra-Cellular Therapies, I... (ITCI) | 31-Dec-21 | Grant | 300 | $52.34 | $15,702.00 | < 1% 303.19K to 303.49K | (14%) |